FindTrial
Sign In

The study of effect of metformin on heart disease risk, vitamin levels, and homocysteine in people with and without type 2 diabetes

Correlation between Atherogenic Index of Plasma (AIP), Folic Acid, Vitamin B12, and Homocysteine Levels in Nondiabetic and Type 2 diabetic subjects: Impact of Metformin Treatment. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078624
Enrollment
207
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

Intervention1: NIL: NA Control Intervention1: NIL: NA

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient with type 2 diabetes mellitus with Metformin therapy. 2) Patient with type 2 diabetes mellitus without Metformin therapy. 3) Age more than 30 yr.

Exclusion criteria

Exclusion criteria: 1. Patient with other systemic disease. 2. Patient with comorbidities. 3. Immunocompromised patients

Design outcomes

Primary

MeasureTime frame
Assessment of cardiovascular risk in nondiabetic and type 2 diabetic patients with or without metformin treatment.Timepoint: Assesment will be done at the end of 12 months—

Secondary

MeasureTime frame
NILTimepoint: NA—

Countries

India

Contacts

Public ContactDr.Ashish Anjankar

Datta Meghe Institute of Higher Education and Research

ashish.anjankar@gmail.com9970951055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026